...
首页> 外文期刊>Fuel Cell Industry Report >Clinical Trials of the America's Inc. enters into binding letter of intent with Next Fuels
【24h】

Clinical Trials of the America's Inc. enters into binding letter of intent with Next Fuels

机译:美国公司的临床试验与Next Fuels签订具有约束力的意向书

获取原文
获取原文并翻译 | 示例
           

摘要

Clinical Trials of America Inc. has entered into a binding letter of intent to sell shares equal to approximately 75% of its issued and outstanding shares to Next Fuel Inc. Next Fuel is the developer of a proprietary "On Demand" Hydrogen Generation System that is used as fuel for fuel cells.
机译:美国临床试验公司已签署有约束力的意向书,将其大约75%已发行和已发行股份的股份出售给Next FuelInc.。NextFuel是专有的“按需”制氢系统的开发商,该系统用作燃料电池的燃料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号